XPH

SPDR S&P Pharmaceuticals ETF

Up$38.89
+$0.01
(+0.03%)
As of 4:10:00 PM EDT | 4/18/19  |  Market Closed

XPH Trading Data

Open

$38.96

Low Price

$38.24

High Price

$39.11

Previous Last Price

$38.88

Bid Size

$38.6 X 2000

Ask Size

$39.62 X 2000

XPH Portfolio Data

AUM

$225,627,800

Shares

5,800

PE Ratio

9.53

Price / Book Ratio

2.45

Expense Ratio

0.35

Net Asset Value

$38.90

Volume

Volume

84,845

Avg. Volume (YDT)

62,802

Dollar Volume

$3,131,991

Weekly Avg. Volume

73,889

Monthly Avg. Volume

58,797

Quarterly Avg. Volume

56,910

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Perrigo Co. Plc (PRGO)
4.96%
Elanco Animal Health Inc. (ELAN)
4.93%
Zoetis Inc. Class A (ZTS)
4.89%
Jazz Pharmaceuticals Plc (JAZZ)
4.67%
Mylan N.V. (MYL)
4.64%
Allergan plc (AGN)
4.57%
Pfizer Inc. (PFE)
4.56%
Johnson & Johnson (JNJ)
4.56%
Merck & Co. Inc. (MRK)
4.43%
Nektar Therapeutics (NKTR)
4.33%

Total XPH Holdings

Total Holdings: 44

Perrigo Co. Plc (PRGO)
4.96%
Elanco Animal Health Inc. (ELAN)
4.93%
Zoetis Inc. Class A (ZTS)
4.89%
Jazz Pharmaceuticals Plc (JAZZ)
4.67%
Mylan N.V. (MYL)
4.64%
Allergan plc (AGN)
4.57%
Pfizer Inc. (PFE)
4.56%
Johnson & Johnson (JNJ)
4.56%
Merck & Co. Inc. (MRK)
4.43%
Nektar Therapeutics (NKTR)
4.33%
Eli Lilly and Company (LLY)
4.32%
Bristol-Myers Squibb Company (BMY)
4.08%
Mallinckrodt Plc (MNK)
3.94%
Catalent Inc (CTLT)
3.91%
Horizon Pharma plc (HZNP)
3.31%
Medicines Company (MDCO)
3.14%
Endo International Plc (ENDP)
2.55%
Aerie Pharmaceuticals Inc. (AERI)
2.43%
Pacira Biosciences Inc. (PCRX)
2.37%
Supernus Pharmaceuticals Inc. (SUPN)
2.27%
Corcept Therapeutics Incorporated. (CORT)
1.97%
Innoviva Inc. (INVA)
1.92%
Prestige Consumer Healthcare Inc (PBH)
1.79%
MyoKardia Inc. (MYOK)
1.74%
Zogenix Inc. (ZGNX)
1.52%
Reata Pharmaceuticals Inc. Class A (RETA)
1.37%
TherapeuticsMD Inc. (TXMD)
1.32%
Amneal Pharmaceuticals Inc. Class A (AMRX)
1.26%
Omeros Corporation (OMER)
1.13%
Akorn Inc. (AKRX)
0.93%
Intersect ENT Inc (XENT)
0.83%
Revance Therapeutics Inc. (RVNC)
0.64%
Tricida Inc (TCDA)
0.59%
CymaBay Therapeutics Inc. (CBAY)
0.58%
Collegium Pharmaceutical Inc. (COLL)
0.56%
Intra-Cellular Therapies Inc. (ITCI)
0.54%
Wave Life Sciences Ltd. (WVE)
0.53%
Phibro Animal Health Corporation Class A (PAHC)
0.51%
Theravance Biopharma Inc (TBPH)
0.5%
ANI Pharmaceuticals Inc. (ANIP)
0.48%
Amphastar Pharmaceuticals Inc (AMPH)
0.39%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.05%
SPDR S & P Pharmaceuticals ETF (XPH)
0%
U.S. Dollar
0%

XPH Technicals

Alpha

-11.36

Beta

1.42

Leverage

Long

Standard Deviation

3.25

XPH Dividends

Dividend Date

2019-03-18

Latest Dividend

0.068

Annual Dividend

0.29

Annual Dividend Rate

0.29

Annual Dividend Yield

0.74

XPH Performance

YTD Return

6.2%

1 Year Return

-8.19%

3 Year Return

-13.73%

5 Year Return

-17.46%

10 Year Return

197.02%

XPH Related Articles